Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Genetic Engineering

1594

Genetic Engineering (GE), or genetic modification, is the manipulation of an organism’s DNA sequence. Using recombinant DNA technology, or gene splicing, segments of a DNA are taken out and replaced changing the genetic makeup of the organism.

Applications of GE include genetically modified foods, gene therapy, germ-line therapy and cloning. Although they have all spurred debate, one topic, which has been particularly controversial, is the use of genetically modified foods.

Genetically modified foods have found their place in today’s world with the decreasing effectiveness of synthetic pesticides used in agriculture and the world hunger crisis. Genetically modified foods can decrease the need for pesticides by increasing the crops resistance to these harmful chemicals. This can increase the harvest of many chief crops, in turn warding off starvation in many global populations.

Despite the benefits of genetically modifying food, critics have numerous concerns. One argument centers on its effect on wild populations, fearing that genetically engineered crops might transmit their modified genes to convention crops or species, creating organisms which humans have no defense for.

Another argument centers on allergenicity. There is the potential for genetically modified foods to contain allergenic proteins, making these foods dangerous for some people.

RSS Feeds

All reports in Genetic Engineering

< prev 1  2  3  next >
Value-Added Produce
4/1/1995 | published by: Kalorama Information
... is value-added. Examines demand and supply in the market; product innovations; technological developments in packaging, sanitation, refrigeration, and category management; and the globalization of the produce industry. Consumer demographic trends are analyzed, and leading national ...  |  more...
$1,625.00
Market for Bioremediation Products and Services
9/1/1995 | published by: Kalorama Information
... and processes, the regulatory and legislative environment, alternative remediation cost/benefit comparisons, potential sites for bioremediation, and new product advances through genetic engineering. Important end-use markets are thoroughly evaluated and trends in international markets are analyzed. ...  |  more...
$1,625.00
Vaccines: World Market
10/1/1995 | published by: Kalorama Information
... to the future of disease prevention. Also details the life-saving potential of therapeutic vaccines (theraccines) for treating cancer, AIDS, autoimmune diseases and diabetes. Forecasts sales for those products in development; discusses what role key companies ...  |  more...
$1,625.00
Market for Healthy Prepared Foods
2/1/1996 | published by: Kalorama Information
... 1995 and provides forecasts through 2000. You'll find complete overviews of the changing consumer environment, opportunities for food producers and marketers, and a discussion of various distribution channels. You'll also get detailed profiles of such ...  |  more...
$1,625.00
Cancer Therapeutics Market
5/1/1996 | published by: Kalorama Information
... agents, cancer vaccines, genetic therapies, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled.  |  more...
$812.00
The Market for Cancer Therapeutics
4/1/1998 | published by: Kalorama Information
... restoration, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled. Individual sections are available.  |  more...
$2,437.50
The Market for Vaccines
2/1/2000 | published by: Kalorama Information
... the future of the vaccines industry with an understandable, comprehensive overview of the technological advances in bioengineering and recombinant DNA research. Included are forecast sales for vaccine products to the year 2004, and an assessment ...  |  more...
$450.00
Antisense Therapy: Technical Aspects and Commercial Opportunities
3/1/2000 | published by: Business Insights
... this report analyses the commercial premise of each of the antisense technologies and forecasts future market shares. The report also investigates the challenges of drug delivery with antisense oligonucleotides and the role of gene therapy.  |  more...
$2,875.00
Commercial Biotechnology Review
6/1/2000 | published by: BCC Research
... vital one for business planning, research planning, and marketing efforts. All aspects of the industry are covered, including bioprocess technology, biopharmaceuticals in all the major categories, antibodies, enzymes, agriculture, food, technology transfer licensing and finance.  |  more...
$2,012.50
China Pharmaceuticals Guide: New Policy and Regulation
6/1/2000 | published by: Urch Publishing
... Concept Consulting, the Chinese Information Centre of The State Drug Administration (SDA) and Informa Pharmaceuticals have prepared the China Pharmaceuticals Guide - a definitive reference manual to the regulation of pharmaceuticals in this exciting market.  |  more...
$360.00
Protein Drugs: Manufacturing Technologies
7/1/2000 | published by: BCC Research
... commercial production, choice of method, scale-up, upstream manipulation and more, and addresses important issues such as glycosylation, contamination and regulations. The report covers source extraction, fermentation, cell culture, chemical synthesis, and transgenic animals, as well ...  |  more...
$3,967.50
Brand Strategies for Food & Drink
7/1/2000 | published by: Business Insights
... projections can be made, this report examines how new trends are driven by demographic and cultural changes, discusses the impact of globalization on marketing and consumption, and tracks the potential impact of eCommerce and the ...  |  more...
$1,530.00
The New Future of Biotechnology: Enabling Technologies and Star Products
1/1/2001 | published by: BCC Research
... therapy treatments for cancer and for other disorders, antisense drugs and antibodies. The forecast period is 1999 to 2005, and the scope of the market is worldwide. A detailed discussion and analysis of the effect ...  |  more...
$4,198.00
Special Package: Current Developments in Immunotherapy Markets and Technology and Advances in Cancer Therapy
4/1/2001 | published by: Kalorama Information
... major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides ...  |  more...
$5,950.00
Emerging Technologies and Opportunities in Structural Tissue Engineering
8/1/2001 | published by: Kalorama Information
... under development including: Isolated cells used for implantation Cells combined with biomaterials and active substances Biomaterial based scaffolds Administration of active substances to affect endogenous tissue In addition, key technologies used in research as well ...  |  more...
$2,437.00
Transfection and Gene Transfer: Technologies and Markets
1/1/2002 | published by: Kalorama Information
... the gene therapy field, scientists have been focused on trying to transfer a gene to a cell, have the cell uptake the gene, and then have the gene produce a protein. Researchers, however, have not ...  |  more...
$1,875.00
Opportunities in Stem Cell Technology
2/1/2002 | published by: Kalorama Information
... identify those technologies and opportunities in the United States with the greatest future opportunities, the opportunities to develop enabling technologies in the field, and the organizations and laboratories performing current research. In addition, a section ...  |  more...
$2,625.00
Next Generation Drugs: Acceleration Through Innovation
3/1/2002 | published by: Business Insights
... of a company's R&D focus, pipeline commitments, synergies to enhance R&D programmes, and analysis of risk and competition. Next Generation Drugs: Acceleration through innovation is a new management report examining the technological innovations that are ...  |  more...
$2,875.00
The Outlook for Organic Food and Drinks: Consumer trends and new product development
3/1/2002 | published by: Business Insights
... for success lie by understanding the momentum behind the growth of the organic market. The report provides unique comparative 1995-2000 and 2005 forecasted data on the organic market, with a comprehensive analysis of over 400 ...  |  more...
$1,140.00
Stem Cell and Progenitor Cell Therapy: Current Uses and Future Possibilities
3/1/2002 | published by: BCC Research
... neurodegenerative systems, the use of mesenchymal stem cells to repair bones and joints, liver stem cells for liver failure, and the potential use of "therapeutic cloning" to repair other tissues. This report is necessary and ...  |  more...
$4,198.00
Agbiotech: Genetically Altered Traits in Crop/Food Products and Ingredients
3/1/2002 | published by: BCC Research
... agbiotech crops and their products and analyzes their potential market value, taking into account major issues that are critical to the health of the industry such as regulation, international trade and consumer acceptance. Food products ...  |  more...
$3,968.00
The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market
7/1/2002 | published by: Takeda Pacific
... thing as bio-IT. Companies involved in this interesting industry have made it possible for several genomics companies to sequence sections of the human genome as well as do work in proteomics. The bio-IT market is ...  |  more...
$1,995.00
Industries in Transition Industry Review
9/1/2002 | published by: BCC Research
... on our monthly newsletter, Industries in Transition, which gives its readers immediate insights into fast breaking changes that can spell profits or opportunities for growth in a broad range of industries. As you well know, ...  |  more...
$2,128.00
Medical and Biological Sensors and Sensor Systems: Markets, Applications, and Competitors Worldwide
9/1/2002 | published by: Kalorama Information
... stakes are high for those in the business or thinking about entering. This new study from Kalorama attacks the field from the point of view of current R&D, technology and innovation, with an eye to ...  |  more...
$2,625.00
The Future Battle Between Biopharmaceuticals and Biogenerics
10/30/2003 | published by: BioSeeker Group AB
... have reviewed the positions of the FDA and the EMEA, the views on regulatory precedent cases from the biologics industry, the possible route of a comparability study approval, the scope of clinical trial necessary, and ...  |  more...
$3,375.00
< prev 1  2  3  next >